Health Care/Hospital
Singapore-based Impact Investor Heritas Capital Announces US$60M First Close of Heritas Growth Fund III to Back Asian Emerging Champions Driving Sustainable Covid-19 Recovery
* Pan-Asia Impact Fund to back high-growth emerging champions developing smart platforms that enhance access to affordable quality healthcare and education for sustainable post-Covid recovery, in line with UN Sustainable Development Goals (SDGs) * Builds on successful track record of earlier ...
2021-06-01 09:00
1963
Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China
SAN FRANCISCO and SUZHOU, China, June 1, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...
2021-06-01 08:00
3824
PENTAX Medical and Vedkang Establish Endoscopic Therapeutics Joint Venture
TOKYO, May 31, 2021 /PRNewswire/ -- PENTAX Medical (a division of HOYA Group) and Jiangsu Vedkang Medical Science and Technology Co., Ltd (Vedkang) today announced the establishment of a joint venture- PENTAX Medical Therapeutics ( Jiangsu) Co., Ltd.(*) to develop single-use therapeutics products ...
2021-05-31 21:00
2051
PolyU develops biomimetic nanosheet for cancer therapy and imaging
HONG KONG, May 31, 2021 /PRNewswire/ -- A research team from the Department of Applied Biology and Chemical Technology (ABCT) of The Hong Kong Polytechnic University (PolyU) has developed a novel type of biomimetic nanosheet with a multi-modal imaging function, which can track tumour development ...
2021-05-31 19:42
2219
RhoVac Confirms Forecast - BRaVac Phase IIb study recruitment to close in Quarter 3 2021
STOCKHOLM, May 31, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today,May 31, 2021, that it confirms its previous forecast to be able to conclude recruitment for its multi-centre BRaVac Phase IIb study in Quarter 3 2021. Also, all new US clinics hav...
2021-05-31 19:33
1572
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery
SINGAPORE, May 31, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, announced the approval by the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for MLC1501 in traumatic brain injury (TBI). Moleac is dedicated in finding, devel...
2021-05-31 18:33
1322
Mindray Defines Future of Imaging Technologies with New General Imaging, Women's Healthcare and Cardiology Ultrasound Solutions
SHENZHEN, China, May 31, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has announced the launch of its new General Imaging, Women's Healthcare, and Cardiology ultrasound solutions onMay 28, 2021. Underpinned by the theme "In...
2021-05-31 10:15
6653
Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
* HMBD-002 is the only IgG4 isotype anti-VISTA antibody currently in development * HMBD-002 is anticipated to enter a Phase 1 clinical trial in 2021 HOUSTON andSINGAPORE, May 31, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing pr...
2021-05-31 10:00
1681
OPAS: A Game-Changer in Post Covid-19 Landscape
PORTLAND, Ore., May 31, 2021 /PRNewswire/ -- We believe that it's safe to say that Covid-19 will likely be one of the defining events of 2021, and it will further have implications that will keep surfacing for years to come. The situation is drastically changing, and the amount of people that are...
2021-05-31 09:00
1722
An Taiwanese Hearing-impaired Actor, Easton Dong Calls Out the "Listen Love" Project, to Raise Concerns for Hearing-impaired Students during the Covid-19 Pandemic.
TAIPEI, May 31, 2021 /PRNewswire/ -- The "Listen Love" donation project, led by Easton Dong, a hearing-impaired actor inTaiwan, and co-sponsored by TaerInno, aims to bring transparent masks to hearing-impaired students. Mr. Dong advocates this campaign to bring people awareness of difficulties en...
2021-05-31 08:00
1570
Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.
SEOUL, South Korea, May 30, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced onMay 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc. ("Rosvivo"), an American new drug developer, for about5.5 million U.S. dollars. As a result, Nexturn...
2021-05-30 22:00
3177
IFF 2021 Opens with Green Initiatives for a More Sustainable Future
BEIJING, May 29, 2021 /PRNewswire/ -- International Finance Forum (IFF) starts its two-day 2021 Spring Meetings today. EntitledGlobal Governance and Development in the Post-Pandemic Era, the meeting aims to provide a platform for in-depth discussions on international cooperation and global govern...
2021-05-29 20:56
3759
Second Global Health Forum of Boao Forum for Asia to be Held in Qingdao, Discussing "Health for All"
QINGDAO, China, May 28, 2021 /PRNewswire/ -- The Boao Forum for Asia (BFA) will hold the second Global Health Forum at the China Railway Qingdao World Expo City Conference Center inQingdao, China, from June 1-4, 2021. With the slogan "Health for All", the conference will convene representatives f...
2021-05-28 22:23
4091
Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease Patient Management
SHANGHAI, May 28, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, announced the launch of the patient management service focusing on the profes...
2021-05-28 18:30
4696
Year-end report, May-April 2020/21
Accelerated order growth STOCKHOLM, May 28, 2021 /PRNewswire/ -- During Elekta's fourth quarter, we drove strong order growth in all regions – both from market growth and market share gain – and we received our 100th Unity order. Installation volumes were similar to levels in the fourth quarter ...
2021-05-28 14:24
12874
FRISO Launches Search for Chief Poop Officers on World Digestive Health Day
SINGAPORE, May 28, 2021 /PRNewswire/ -- FRISO today announced its nationwide search for 'Chief Poop Officers' in every household across the island as part of its efforts to advocate good digestive health and nutrient absorption in young children. Launched to coincide with World Digestive Health D...
2021-05-28 13:06
2219
Zimmer Biomet's ROSA Knee System awarded Orthopaedic Product Innovation of the Year at the recently concluded Healthcare Asia Medtech Awards 2021.
SINGAPORE, May 28, 2021 /PRNewswire/ -- Zimmer Biomet, a global leader in musculoskeletal healthcare, today announced that Zimmer Biomet's ROSA Knee was awarded the Orthopaedic Product Innovation of the Year at the recently concluded 2021 Healthcare Asia Medtech Awards. The inaugural 2021 Heal...
2021-05-28 09:00
3625
International Finance Corporation and Mitsui to invest c.US$60 million in Singapore-based MiCare Health Technologies
SINGAPORE, May 28, 2021 /PRNewswire/ -- MiCare HealthTEC Holdings Pte Ltd ("MiCare"), a subsidiary of Zuellig Pharma and a leading medical claims administrator in the region, has announced that the International Finance Corporation (IFC), a member of the World Bank Group, and Mitsui & Co. (Asia ...
2021-05-28 09:00
3083
CStone Announces the First-in-Class Registrational Clinical Trial of Sugemalimab Met its Primary Endpoint in Stage III NSCLC and Plans to Submit a New Drug Application
* Sugemalimab becomes the world's first anti-PD-1/PD-L1 monoclonal antibody to successfully improve progression-free survival (PFS) in patients with stage III non-small-cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy * Sugemalimab is also t...
2021-05-28 08:10
7314
Antengene Announces First Patient Dosed in Phase I/II Trial of Eltanexor for the Treatment of Myelodysplastic Syndrome
SHANGHAI and HONG KONG, May 28, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
2021-05-28 08:00
2616
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 302 media titles]
2024-04-15 17:33
AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 295 media titles]
2024-04-12 15:14
LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
[Picked up by 276 media titles]
2024-04-11 11:00
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 275 media titles]
2024-04-15 08:00
Most Read
LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
2024-04-11 11:00
6669
AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
2024-04-12 15:14
6390
XCMG Machinery Launches Premium G2 Crane Brand
2024-04-12 14:39
6324
